R&D Focus

Innovation

R&D Offer

Icon Offer

JennyHub

A Proposed Innovation Center

will offer a wide range of studies and tests

Looking to the Future

One project in development is JennyHub, a proposed new innovation center which will be focused on exploring cannabinoid-derived formulas to advance human well-being and quality of life in women’s health, sleep, pain mitigation, and other areas.

At JennyHub, which will be co-located at Jenny’s Hudson Valley processing facility, Intriguing Labs and Jenny’s will collaborate with local companies, universities, hospitals, and local and state offices, while advancing cannabis knowledge and innovations in New York State.

INTRIGUING LABS

INTRIGUING LABS is dedicated to the accelerating research, development, and commercialization of innovative life sciences solutions including cannabinoids. The company and its leadership have been at the forefront of cannabis innovation, conducting clinical trials, and running sophisticated product development for the last 10 years.

At in the end of each study / service, we will provide a professional report that will certify a product with a stamp of approval.

See http://www.intriguinglabs.com for more info.

Intriguing Labs

As the focus on assuring quality and predictability in the New York cannabis market continues to grow, JennyHub will become a trusted, independent resource, including a

Contract Research Organization (“CRO”).

Cannabis products will be rigorously considered for efficacy, safety, bioavailability; as well as sophisticated formulations including better taste & consistency, and marketed with a stamp of approval.

Generic Gummies

Formula Development

Formulation of the various cannabinoids for improved local and systemic bioavailability and better performances. We will also develop co-formulations of cannabinoids together with other beneficial ingredients.

Regulatory Consulting

Without the appropriate regulatory approvals by the regulatory authorities, such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), a product could not be placed on the market. Regulatory consulting is important from the very early stages in order to assure an appropriate R&D course.

Nutraceutical Studies

Nutraceuticals (dietary supplements) are substances that provide medical or health benefits, including the prevention and treatment of disease. Although nutraceuticals are not considered drugs and no scientific claims can be made, the safety and efficacy of the products should be carefully tested in order to provide consumers with a safe and efficient product, usually consumed for long periods

Tests, Studies and Protocols

A trial must be carefully designed. We will prepare protocols that answer the clients’ demands in terms of clinical objectives as well as budget & schedule

Business Development

Leveraging our extensive network, and long time industry experience in biotech, agritech, and foodtech we are developing strategic partnerships between leading companies and creating new business opportunities to bring to market breakthrough innovations

IP Evaluation and Due Diligence

Intellectual Properties (IPs) and patents are real assets, and protecting them is the most important part. We will provide an evaluation of IP as a stand-alone service or as a part of a Due Diligence that analyses the current status of the development including regulatory status, IP, market analysis, etc., as well as market potential and future steps to be performed. Our Due Diligence will be performed for all types of investors as well as for internal purposes.

Safety & Efficacy Studies

Safety studies in the laboratory are a crucial stage in any product development. Efficacy trials will allow us to evaluate new products versus other products available in the marketplace. The tailored combination of the two leads to a shorter and more efficient R&D course, in terms of time & costs.

Bioavailability Tests

Bioavailability is a key factor, as it defines how much of the active ingredient will reach the target organ. Low bioavailability will result in low efficacy and can sometimes be associated with high toxicity. We will deal with both local (specific organs) and systemic (plasma) bioavailability and specific formulations targeted for improved bioavailability.

Copyright © 2024 Jenny Loves Me |

Site by CannaPlanners

Are you over 21 years of age?

You are not old enough to view this website.